
LOS ANGELES, Jan. 9 (UPI) -- A U.S. study documents the therapeutic effect -- within minutes -- of the drug etanercept injected into the spine of an Alzheimer's patient.
Etanercept, also known as Enbrel -- used to treat autoimmune diseases such as rheumatoid arthritis -- binds and inactivates excess tumor necrosis factor-alpha, or TNF. Normally, TNF finely regulates the transmission of neural impulses in the brain.
Study authors Dr. Edward Tobinick of the University of California-Los Angeles and Dr. Hyman Gross of the University of Southern California hypothesize that elevated levels of TNF in Alzheimer's disease interfere with this regulation. Excess TNF-alpha has been documented in the cerebrospinal fluid of patients with Alzheimer's.
The article discusses one patient but many other patients with mild to severe Alzheimer's received the treatment and all have shown sustained and marked improvement, the news release said.
The finding are published in the Journal of Neuroinflammation.
|
|
|
|
|
|
| Additional Health News Stories | |
WASHINGTON, May 28 (UPI) --
Rolling Thunder motorcyclists moved into Washington as part of the annual Memorial Day weekend ride held in remembrance of war dead and those missing in action.
|
SAN FRANCISCO, May 28 (UPI) --
The Golden Gate Bridge celebrated its 75th birthday in the San Francisco Bay with fireworks.
|
Wedding parties told to quiet down ... Jersey falcons put up a squawk ... Man charged in drive-through gun incident ... iCloud sends pics of suspected phone thief ... Watercooler stories from UPI.
|
To avoid a meltdown in 2006, Ford Motor Co. mortgaged the farm putting up its assets – including its Blue Oval logo, and F-150 pickup and iconic Mustang trademarks – to secure $23.5 billion in credit.
|
| Stories | Photos | People | Comments |
View Caption